secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K/A
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001213900-24-014316
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics still not in compliance with Nasdaq minimum bid price; requests extension
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Sept 6, 2023 for bid price below $1.00 for 30 consecutive business days.
- Stock traded above $1.00 for 14 consecutive days Jan 19-Feb 7, 2024, but Nasdaq has not confirmed compliance.
- Company intends to request an additional 180-day compliance period under Nasdaq rules.
- If compliance not regained, delisting notice would trigger a hearing; reverse stock split considered as option.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024014316/0001213900-24-014316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024014316/ea193846-8ka1_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-014316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer